Tempus AI Inc. (NASDAQ:TEM) stock surged on Thursday. The sharp upward price action follows a major company announcement made on Wednesday, which triggered heavy buying momentum.

Digital Pathology Consortium Sparks Momentum

The primary catalyst behind the stock rally is the launch of a first-of-its-kind digital pathology open-source consortium.

Named the IMS Open-Source Consortium, the initiative aims to accelerate the democratization and standardization of digital pathology. Tempus AI is spearheading the collaborative project alongside pioneering founding academic members Yale New Haven Hospital (YNHH) and Memorial Sloan Kettering Cancer Center (MSK).

Read Also: Space Stocks Bleed: Redwire, Momentus Down More Than 20% As SpaceX IPO Fatigue Hits

Open-Source Tech Seeds Ecosystem

To jumpstart the collaborative framework, Tempus announced it will open-source its existing Paige Image Management System (IMS). This includes its proprietary slide viewer (FullFocus), case management solution (FullFolio), and advanced AI orchestration and integration modules. The initiative provides a clinical-grade baseline solution to medical institutions globally.

Leadership Visions On AI Transformation

Management notes that the consortium operates independently of Tempus’ current commercial offerings. Razik Yousfi, SVP and GM of AI Products at Tempus, emphasized the clinical value of the move, stating, “Advances in deep learning and AI foundation models are enabling digital pathology to generate powerful insights directly from whole slide images, from cancer detection to molecular profiling.”

Academic Partners Back Interoperability

Medical experts highlight that the sector currently lacks open-access, clinical-grade infrastructure. Chen Liu, Chief of Pathology at YNHH, noted, “Open innovation and shared standards will be essential to accelerating adoption, improving workflow efficiency, and enhancing patient care.”

Tempus AI Stock Short Interest Report

Short interest in Tempus AI increased during the last reporting period, rising from 26.76 million to 35.17 million. This put 35.52% of the company’s publicly available shares short.

Based on the recent average volume of 7.21 million shares traded per day, it would take 4.88 days for holders of this short interest to close out their positions without sending the stock sharply higher.

TEM Stock Price Activity: Tempus AI shares were up 9.55% at $52.04 at the time of publication on Thursday, according to Benzinga Pro data.

Read Also: Broadcom Stock Just Slid 15% — But The Selloff May Have Fixed A Bigger Problem

Image via Shutterstock